ForFarmers NV (FFARM)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 5.700 |
|---|---|
| 52-week range | 4.165 – 6.920 |
| Return, 1 month / 3 months | −6.3% / −5.8% |
| Return, 1 year / 3 years | +39.1% / +177.4% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 25.0% |
| Worst drawdown (1 year) | -16.0% |
| Average daily value traded | 0.59M EUR |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ForFarmers is an animal feed company based in the Netherlands. It makes compound feed and related nutritional products for livestock, including dairy cattle, pigs, poultry and other farm animals. Its customers are farmers and livestock producers who buy feed for their herds and flocks. The company also offers advice and support services connected with animal nutrition. It operates across several European countries, serving agricultural businesses in its home market and neighbouring regions.
The shares are listed on the Euronext Amsterdam in Netherlands under the code FFARM, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ForFarmers NV (FFARM) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 5.700 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 46 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.1% and over the last three months it fell 5.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.9% | ||
| From 52-week high | -16.8% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.8% | ||
| 6-month return | -5.5% | ||
| 12-month return, skipping the last month | 48.4% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.0% | ||
| Liquidity | 39 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.59M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −6.3% |
| 3 months | −5.8% |
| 6 months | −5.5% |
| 1 year | +39.1% |
| 3 years | +177.4% |
| 5 years | +75.6% |
Signals
| 50-day / 200-day average | 5.769 / 5.934 |
|---|---|
| Golden / death cross (60 days) | Death, 15 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.111 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | EUR 0.3000 |
| 23 Apr 2025 | EUR 0.2000 |
| 15 Apr 2024 | EUR 0.1500 |
| 17 Apr 2023 | EUR 0.2000 |
| 20 Apr 2022 | EUR 0.1900 |
| 27 Apr 2021 | EUR 0.2900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.